查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386354

阿兹海默症诊断市场报告：2030 年趋势、预测和竞争分析

Alzheimer's Disease Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

阿兹海默症的趋势和预测

预计到 2030 年，全球阿兹海默症诊断市场将达到约 54 亿美元，2024 年至 2030 年年复合成长率为 7.8%。该市场的主要驱动因素是阿兹海默症的盛行率不断上升、对早期诊断的需求不断增加以及医疗技术的快速进步。全球阿兹海默症诊断市场前景广阔，为诊所、医院、诊断中心、製药公司和学术研究中心带来未来性。

阿兹海默症诊断市场洞察

Lucintel 预测，大脑影像检查将在预测期内经历最高的增长。

由于阿兹海默症的高盛行率和新诊断技术的快速采用，预计北美在预测期内将出现最高的增长。

市场规模/估计：以金额的阿兹海默症诊断市场规模估计（10 亿美元）。

趋势和预测分析：按细分市场和地区分類的市场趋势（2018-2023）和预测（2024-2030）。

細項分析：按类型、最终用途和地区金额（十亿美元）估计阿兹海默症诊断市场规模。

区域分析：北美、欧洲、亚太地区以及世界其他地区、中东和非洲的阿兹海默症诊断市场细分。

成长机会：按类型、最终用途和地区分析阿兹海默症诊断市场的成长机会。

策略分析：阿兹海默症诊断市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球阿兹海默症诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球阿兹海默症诊断市场趋势（2018-2023）和预测（2024-2030）
  • 按类型分類的全球阿兹海默症诊断市场
    • 神经系统
    • 检查
    • 基因检测
    • 轻度精神状态检查
    • 脑部影像检查
  • 全球阿兹海默症诊断市场（按最终用途）
    • 诊所
    • 医院
    • 诊断中心
    • 製药公司
    • 学术研究中心

第4章2018-2030年分地区市场趋势及预测分析

  • 全球阿兹海默症诊断市场（按地区）
  • 北美阿兹海默症诊断市场
  • 欧洲阿兹海默症诊断市场
  • 亚太阿兹海默症诊断市场
  • 其他地区阿兹海默症诊断市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球阿兹海默症诊断市场成长机会（按类型）
    • 全球阿兹海默症诊断市场成长机会（按最终用途）
    • 全球阿兹海默症诊断市场按地区成长机会
  • 全球阿兹海默症诊断市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球阿兹海默症诊断市场的能力
    • 全球阿兹海默症诊断市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • AbbVie
  • AC Immune
  • AMARANTUS BIOSCIENCE
  • Anavex Life Sciences
  • Eli Lilly and Company
  • AXON Neuroscience
  • Sio Gene Therapies
简介目录

Alzheimer's Disease Trends and Forecast

The future of the global alzheimer's disease diagnostic market looks promising with opportunities in the clinic, hospital, diagnostic center, pharmaceutical company, and academic research center markets. The global alzheimer's disease diagnostic market is expected to reach an estimated $5.4 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of alzheimer's disease, rising demand for early diagnosis, and rapid advancement in healthcare technology.

A more than 150-page report is developed to help in your business decisions.

Alzheimer's Disease by Segment

The study includes a forecast for the global alzheimer's disease by type, end use, and region.

Alzheimer's Disease Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Nervous System
  • Examination
  • Genetic Testing
  • Minor Mental State Examination
  • Brain Imaging Tests

Alzheimer's Disease Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Clinics
  • Hospitals
  • Diagnostic Centers
  • Pharmaceutical Companies
  • Academic Research Centers

Alzheimer's Disease Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Alzheimer's Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies alzheimer's disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the alzheimer's disease companies profiled in this report include-

  • AbbVie
  • AC Immune
  • Amarantus Bioscience
  • Anavex Life Sciences
  • Eli Lilly And Company
  • AXON Neuroscience
  • Sio Gene Therapies

Alzheimer's Disease Diagnostic Market Insights

Lucintel forecasts that brain imaging test is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to high prevalence of alzheimer's disease and rapid adoption of new diagnostic technologies in the region.

Features of the Global Alzheimer's Disease Diagnostic Market

Market Size Estimates: Alzheimer's disease diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Alzheimer's disease diagnostic market size by type, end use, and region in terms of value ($B).

Regional Analysis: Alzheimer's disease diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the alzheimer's disease diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the alzheimer's disease diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the alzheimer's disease diagnostic market size?

Answer: The global alzheimer's disease diagnostic market is expected to reach an estimated $5.4 billion by 2030.

Q.2 What is the growth forecast for alzheimer's disease diagnostic market?

Answer: The global alzheimer's disease diagnostic market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the alzheimer's disease diagnostic market?

Answer: The major drivers for this market are increasing prevalence of alzheimer's disease, rising demand for early diagnosis, and rapid advancement in healthcare technology.

Q4. What are the major segments for alzheimer's disease diagnostic market?

Answer: The future of the alzheimer's disease diagnostic market looks promising with opportunities in the clinic, hospital, diagnostic center, pharmaceutical company, and academic research center markets.

Q5. Who are the key alzheimer's disease diagnostic market companies?

Answer: Some of the key alzheimer's disease companies are as follows:

  • AbbVie
  • AC Immune
  • Amarantus Bioscience
  • Anavex Life Sciences
  • Eli Lilly And Company
  • AXON Neuroscience
  • Sio Gene Therapies

Q6. Which alzheimer's disease diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that brain imaging test is expected to witness highest growth over the forecast period.

Q7. In alzheimer's disease diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of alzheimer's disease and rapid adoption of new diagnostic technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the alzheimer's disease diagnostic market by type (nervous system, examination, genetic testing, minor mental state examination, and brain imaging tests), end use (clinics, hospitals, diagnostic centers, pharmaceutical companies, and academic research centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Alzheimer's Disease Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Alzheimer's Disease Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Alzheimer's Disease Diagnostic Market by Type
    • 3.3.1: Nervous System
    • 3.3.2: Examination
    • 3.3.3: Genetic Testing
    • 3.3.4: Minor Mental State Examination
    • 3.3.5: Brain Imaging Tests
  • 3.4: Global Alzheimer's Disease Diagnostic Market by End Use
    • 3.4.1: Clinics
    • 3.4.2: Hospitals
    • 3.4.3: Diagnostic Centers
    • 3.4.4: Pharmaceutical Companies
    • 3.4.5: Academic Research Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Alzheimer's Disease Diagnostic Market by Region
  • 4.2: North American Alzheimer's Disease Diagnostic Market
    • 4.2.2: North American Alzheimer's Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
  • 4.3: European Alzheimer's Disease Diagnostic Market
    • 4.3.1: European Alzheimer's Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
    • 4.3.2: European Alzheimer's Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
  • 4.4: APAC Alzheimer's Disease Diagnostic Market
    • 4.4.1: APAC Alzheimer's Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
    • 4.4.2: APAC Alzheimer's Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
  • 4.5: ROW Alzheimer's Disease Diagnostic Market
    • 4.5.1: ROW Alzheimer's Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
    • 4.5.2: ROW Alzheimer's Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Alzheimer's Disease Diagnostic Market by Type
    • 6.1.2: Growth Opportunities for the Global Alzheimer's Disease Diagnostic Market by End Use
    • 6.1.3: Growth Opportunities for the Global Alzheimer's Disease Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Alzheimer's Disease Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Alzheimer's Disease Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Alzheimer's Disease Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AbbVie
  • 7.2: AC Immune
  • 7.3: AMARANTUS BIOSCIENCE
  • 7.4: Anavex Life Sciences
  • 7.5: Eli Lilly and Company
  • 7.6: AXON Neuroscience
  • 7.7: Sio Gene Therapies